<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">

  <!-- PACE Progress Bar START -->
  
    
<script src="https://raw.githubusercontent.com/HubSpot/pace/v1.0.2/pace.min.js"></script>

    
<link rel="stylesheet" href="https://github.com/HubSpot/pace/raw/master/themes/orange/pace-theme-flash.css">

  
  

  <!-- PACE Progress Bar START -->

  
  <title>Yujie&#39;s Blog</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  
  
  
  
  <meta name="description" content="文章来源：《经济学人》 The World Ahead 2022 期 Covid-19 栏目 What to expect in year three of the pandemic疫情第三年会发生什么？ The World Ahead 2022New antibody and antiviral treatments, and better vaccines, are on the way新的抗">
<meta property="og:type" content="article">
<meta property="og:title" content="Yujie&#39;s Blog">
<meta property="og:url" content="http://example.com/2021/12/24/Day619-The%20Economist/index.html">
<meta property="og:site_name" content="Yujie&#39;s Blog">
<meta property="og:description" content="文章来源：《经济学人》 The World Ahead 2022 期 Covid-19 栏目 What to expect in year three of the pandemic疫情第三年会发生什么？ The World Ahead 2022New antibody and antiviral treatments, and better vaccines, are on the way新的抗">
<meta property="og:locale">
<meta property="og:image" content="https://www.economist.com/img/b/1920/1080/90/media-assets/image/20211118_STP004.jpg">
<meta property="og:image" content="https://www.economist.com/img/b/1280/996/90/media-assets/image/20211118_STC001.png">
<meta property="article:published_time" content="2021-12-24T03:14:13.811Z">
<meta property="article:modified_time" content="2021-12-31T04:57:18.380Z">
<meta property="article:author" content="Chen Yujie">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="https://www.economist.com/img/b/1920/1080/90/media-assets/image/20211118_STP004.jpg">
  
    <link rel="alternate" href="/atom.xml" title="Yujie&#39;s Blog" type="application/atom+xml">
  
  <link rel="icon" href="/css/images/favicon.ico">
  
    <link href="//fonts.googleapis.com/css?family=Source+Code+Pro" rel="stylesheet" type="text/css">
  
  <link href="https://fonts.googleapis.com/css?family=Open+Sans|Montserrat:700" rel="stylesheet" type="text/css">
  <link href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic" rel="stylesheet" type="text/css">
  <link href="https://cdn.bootcss.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet">
  <style type="text/css">
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/9749f0/00000000000000000001008f/27/l?subset_id=2&fvd=n5) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/90cf9f/000000000000000000010091/27/l?subset_id=2&fvd=n7) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/8a5494/000000000000000000013365/27/l?subset_id=2&fvd=n4) format("woff2");font-weight:lighter;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/d337d8/000000000000000000010095/27/l?subset_id=2&fvd=i4) format("woff2");font-weight:400;font-style:italic;}</style>
    
  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Yanone+Kaffeesatz%3A200%2C300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">
  
<link rel="stylesheet" href="/css/style.css">


  
<script src="https://code.jquery.com/jquery-3.1.1.min.js"></script>


  <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="https://netdna.bootstrapcdn.com/bootstrap/3.0.2/css/bootstrap.min.css" >
  <link rel="stylesheet" href="/css/hiero.css" >
  <link rel="stylesheet" href="/css/glyphs.css" >
  
    <link rel="stylesheet" href="/css/vdonate.css" >
  

  <!-- Custom CSS -->
  
<link rel="stylesheet" href="/css/my.css">

  <!-- Google Adsense -->
  
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  <script>
      (adsbygoogle = window.adsbygoogle || []).push({
          google_ad_client: "ca-pub-0123456789ABCDEF",
          enable_page_level_ads: true
      });
  </script>
  
<meta name="generator" content="Hexo 6.3.0"></head>

<script>
var themeMenus = {};

  themeMenus["/"] = "Home"; 

  themeMenus["/archives"] = "Archives"; 

  themeMenus["/categories"] = "Categories"; 

  themeMenus["/tags"] = "Tags"; 

  themeMenus["/about"] = "About"; 

</script>


  <body data-spy="scroll" data-target="#toc" data-offset="50">


  <header id="allheader" class="site-header" role="banner">
  <div class="clearfix container">
      <div class="site-branding">

          <h1 class="site-title">
            
              <a href="/" title="Yujie&#39;s Blog" rel="home"> Yujie&#39;s Blog </a>
            
          </h1>

          
            <div class="site-description">Welcome to my channel</div>
          
            
          <nav id="main-navigation" class="main-navigation" role="navigation">
            <a class="nav-open">Menu</a>
            <a class="nav-close">Close</a>
            <div class="clearfix sf-menu">

              <ul id="main-nav" class="nmenu sf-js-enabled">
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/">Home</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/archives">Archives</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/categories">Categories</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/tags">Tags</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/about">About</a> </li>
                    
              </ul>
            </div>
          </nav>


      </div>
  </div>
</header>


  <div id="originBgDiv" style="background: #fff; width: 100%;">

      <div style="max-height:600px; overflow: hidden;  display: flex; display: -webkit-flex; align-items: center;">
        <img id="originBg" width="100%" alt="" src="">
      </div>

  </div>

  <script>
  function setAboutIMG(){
      var imgUrls = "css/images/pose.jpg,https://source.unsplash.com/collection/954550/1920x1080".split(",");
      var random = Math.floor((Math.random() * imgUrls.length ));
      if (imgUrls[random].startsWith('http') || imgUrls[random].indexOf('://') >= 0) {
        document.getElementById("originBg").src=imgUrls[random];
      } else {
        document.getElementById("originBg").src='/' + imgUrls[random];
      }
  }
  bgDiv=document.getElementById("originBgDiv");
  if(location.pathname.match('about')){
    setAboutIMG();
    bgDiv.style.display='block';
  }else{
    bgDiv.style.display='none';
  }
  </script>



  <div id="container">
    <div id="wrap">
            
      <div id="content" class="outer">
        
          <section id="main" style="float:none;"><article id="post-Day619-The Economist" style="width: 66%; float:left;" class="article article-type-post" itemscope itemprop="blogPost" >
  <div id="articleInner" class="clearfix post-1016 post type-post status-publish format-standard has-post-thumbnail hentry category-template-2 category-uncategorized tag-codex tag-edge-case tag-featured-image tag-image tag-template">
    
    
    <div class="article-meta">
      
	Posted on <a href="/2021/12/24/Day619-The%20Economist/" class="article-date">
	  <time datetime="2021-12-24T03:14:13.811Z" itemprop="datePublished">December 24, 2021</time>
	</a>

      
	<span id="busuanzi_container_page_pv">
	  本文总阅读量<span id="busuanzi_value_page_pv"></span>次
	</span>

    </div>
    <div class="article-entry" itemprop="articleBody">
      
        <p>文章来源：《经济学人》 The World Ahead 2022 期 Covid-19 栏目</p>
<h1 id="What-to-expect-in-year-three-of-the-pandemic"><a href="#What-to-expect-in-year-three-of-the-pandemic" class="headerlink" title="What to expect in year three of the pandemic"></a>What to expect in year three of the pandemic</h1><p>疫情第三年会发生什么？</p>
<h6 id="The-World-Ahead-2022"><a href="#The-World-Ahead-2022" class="headerlink" title="The World Ahead 2022"></a>The World Ahead 2022</h6><h5 id="New-antibody-and-antiviral-treatments-and-better-vaccines-are-on-the-way"><a href="#New-antibody-and-antiviral-treatments-and-better-vaccines-are-on-the-way" class="headerlink" title="New antibody and antiviral treatments, and better vaccines, are on the way"></a>New antibody and antiviral treatments, and better vaccines, are on the way</h5><p>新的抗体和抗病毒治疗方法以及更好的疫苗正在研制中</p>
<p><img src="https://www.economist.com/img/b/1920/1080/90/media-assets/image/20211118_STP004.jpg" alt="img"></p>
<p>Nov 8th 2021</p>
<p>by Natasha Loder: Health-policy editor, The Economist</p>
<p>IN THE WELL-VACCINATED wealthier countries of the world, year three of the pandemic will be better than year two, and covid-19 will have much less impact on health and everyday activities. Vaccines have weakened the link between cases and deaths in countries such as Britain and Israel (see chart). But in countries that are poorer, less well vaccinated or both, the deleterious effects of the virus will linger. A disparity of outcomes between rich and poor countries will emerge. The Gates Foundation, one of the world’s largest charities, predicts that average incomes will return to their pre-pandemic levels in 90% of advanced economies, compared with only a third of low- and middle-income economies. </p>
<figure class="highlight plaintext"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><span class="line">【1】deleterious 有害的</span><br></pre></td></tr></table></figure>

<p>在疫苗接种率良好的世界上较富裕的国家，疫情的第三年将比第二年好，covid-19对健康和日常活动的影响将小得多。在英国和以色列等国，疫苗弱化了病例和死亡之间的联系(见图表)。但在较贫穷、疫苗接种情况较差或两者兼而有之的国家，病毒的有害影响将持续存在。富国和穷国之间的结果差距将会出现。世界最大的慈善机构之一盖茨基金会预测，90%的发达经济体的人均收入将恢复到疫情前的水平，而中低收入经济体的这一比例仅为三分之一。</p>
<p>Although the supply of vaccines surged in the last quarter of 2021, many countries will remain under-vaccinated for much of 2022, as a result of distribution difficulties and vaccine hesitancy. This will lead to higher rates of death and illness and weaker economic recoveries. The “last mile” problem of vaccine delivery will become painfully apparent as health workers carry vaccines into the planet’s poorest and most remote places. But complaints about unequal distribution will start to abate during 2022 as access to patients’ arms becomes a larger limiting factor than access to jabs. Indeed, if manufacturers do not scale back vaccine production there will be a glut by the second half of the year, predicts Airfinity, a provider of life-sciences data. </p>
<p>尽管疫苗的供应在2021年最后一个季度激增，但由于分配困难和疫苗接种犹豫不决，许多国家在2022年的大部分时间内疫苗接种仍然不足。这将导致死亡率和疾病率更高以及经济复苏更弱。随着医务人员将疫苗带到了地球上最贫穷和最偏远的地方，疫苗供应的“最后一英里”问题将变得极其明显。不过，随着“让患者接种疫苗”成为比“获得疫苗”更大的限制因素，在2022年对不平等分配的抱怨将开始减少。事实上，生命科学数据提供商Airfinity预测，如果制造商不缩减疫苗生产，到2022年下半年就会出现疫苗供应过剩的情况。</p>
<p>Booster jabs will be more widely used in 2022 as countries develop an understanding of when they are needed. New variants will also drive uptake, says Stanley Plotkin of the University of Pennsylvania, inventor of the rubella vaccine. Dr Plotkin says current vaccines and tweaked versions will be used as boosters, enhancing protection against variants. </p>
<p>随着各国逐渐了解何时需要加强针，加强针将在2022年得到更广泛的应用。风疹疫苗的发明者，宾西法尼亚大学的Stanley Plotkin说，新的变种也将推动人们去接种。Plotkin博士说，目前的疫苗和经过调整的版本将被用作加强针，增强对变异病毒的保护。</p>
<p><img src="https://www.economist.com/img/b/1280/996/90/media-assets/image/20211118_STC001.png" alt="img"></p>
<p>The vaccination of children will also expand, in some countries to those as young as six months. Where vaccine hesitancy makes it hard for governments to reach their targets they will be inclined to make life difficult for the unvaccinated—by requiring vaccine passports to attend certain venues, and making vaccination compulsory for groups such as health-care workers.</p>
<p>儿童接种疫苗的范围也将扩大，在一些国家也为那些仅有6个月大的儿童接种。对于疫苗的犹豫不决使得政府很难达到他们的目标，他们将倾向于使那些没有接种疫苗的人的生活变得困难，通过要求去特定的场所出示“疫苗通行证”，并要求像医护人员这样的群体强制接种疫苗。</p>
<p>Immunity and treatments may be widespread enough by mid-2022 to drive down case numbers and reduce the risk of new variants. At this point, the virus will become endemic in many countries. But although existing vaccines may be able to suppress the virus, new ones are needed to cut transmission.</p>
<p>到2022年年中，免疫和治疗的普及程度可能足以降低病例数量，并降低新变异的风险。在这一点上，该病毒将成为许多国家的地方病。但是，尽管现有的疫苗可能能够抑制这种病毒，但仍需要新的疫苗来减少传播。</p>
<p>Stephane Bancel, the boss of Moderna, a maker of vaccines based on mRNA technology, says his firm is working on a “multivalent” vaccine that will protect against more than one variant of covid-19. Beyond that he is looking at a “pan-respiratory” vaccine combining protection against multiple coronaviruses, respiratory viruses and strains of influenza. </p>
<p>Moderna是一家基于mRNA技术的疫苗制造商，其老板Stephane Bancel表示，他的公司正在研发一种“多价”疫苗，可以预防一种以上的新冠病毒变体。除此之外，他正在研究一种“泛呼吸道”疫苗，可以对多种冠状病毒、呼吸道病毒和流感毒株进行保护。</p>
<p>Other innovations in covid-19 vaccines will include freeze-dried formulations of mRNA jabs, and vaccines that are given via skin patches or inhalation. Freeze-dried mRNA vaccines are easy to transport. As the supply of vaccines grows in 2022, those based on mRNA will be increasingly preferred, because they offer higher levels of protection. That will crimp the global market for less effective vaccines, such as the XX ones. </p>
<p>covid-19疫苗的其他创新将包括冷冻干燥的mRNA疫苗配方，以及通过皮肤贴片或吸入的疫苗。冷冻干燥的mRNA疫苗易于运输。随着2022年疫苗供应的增长，基于mRNA的疫苗将越来越受欢迎，因为它们提供更高水平的保护。这将会影响全球市场中效果较差的疫苗，比如XX的疫苗。</p>
<p>In rich countries there will also be greater focus on antibody treatments for people infected with covid-19. America, Britain and other countries will rely more on cocktails such as those from Regeneron or AstraZeneca. </p>
<p>在发达国家，也将更加关注对covid-19感染者的抗体治疗。美国、英国和其他国家将更多地依赖Regeneron或阿斯利康等公司的鸡尾酒疗法。</p>
<p>Most promising of all are new antiviral drugs. Pfizer is already manufacturing “significant quantities” of its protease inhibitor. In America, the government has agreed to buy 1.2bn courses of an antiviral drug being developed by Merck, known as molnupiravir. This has shown its efficacy in trials, and the company has licensed it for widespread, affordable production. </p>
<p>其中最有希望的是新型抗病毒药物。辉瑞已经在“大量”生产蛋白酶抑制剂。在美国，政府已经同意购买12亿Merck公司正在研发的抗病毒药物的疗程，该抗病毒药物称为molnupiravir。这已经在试验中证明了它的有效性，该公司已经授权大范围且负担得起的生产。</p>
<p>There are many other antivirals in the pipeline. Antiviral drugs that can be taken in pill form, after diagnosis, are likely to become blockbusters in 2022, helping make covid-19 an ever more treatable disease. That will lead, in turn, to new concerns about unequal access and of misuse fostering resistant strains.</p>
<p>还有许多其他的抗病毒药物正在研发中。诊断后可以药丸形式服用的抗病毒药物很可能在2022年成为热门药物，帮助使covid-19成为一种越来越可治疗的疾病。这反过来又会导致对不平等获取(药物)以及滥用造成耐药菌株的新担忧。</p>
<p>The greatest risk to this more optimistic outlook is the emergence of a new variant capable of evading the protection provided by existing vaccines. The coronavirus remains a formidable foe. </p>
<p>这种更为乐观的前景面临的最大风险是出现一种能够避开现有疫苗提供的保护的新变种。冠状病毒仍然是一个可怕的敌人。</p>
<p><em>Natasha Loder: Health-policy editor, The Economist</em>■</p>

      
    </div>
    <footer class="entry-meta entry-footer">
      
      
      
        <div id="donation_div"></div>


<script src="/js/vdonate.js"></script>

<script>
var a = new Donate({
  title: '如果觉得我的文章对您有用，请随意打赏。您的支持将鼓励我继续创作!', // 可选参数，打赏标题
  btnText: 'Donate', // 可选参数，打赏按钮文字
  el: document.getElementById('donation_div'),
  wechatImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/WeChanQR.png',
  alipayImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/AliPayQR.jpg'
});
</script>
      
            
      
        
	<div id="comment">
		<!-- 来必力City版安装代码 -->
		<div id="lv-container" data-id="city" data-uid="MTAyMC8yOTQ4MS82MDQ5">
		<script type="text/javascript">
		   (function(d, s) {
		       var j, e = d.getElementsByTagName(s)[0];

		       if (typeof LivereTower === 'function') { return; }

		       j = d.createElement(s);
		       j.src = 'https://cdn-city.livere.com/js/embed.dist.js';
		       j.async = true;

		       e.parentNode.insertBefore(j, e);
		   })(document, 'script');
		</script>
		<noscript>为正常使用来必力评论功能请激活JavaScript</noscript>
		</div>
		<!-- City版安装代码已完成 -->
	</div>


      
    </footer>
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2021/12/29/Day620-The%20Economist/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          (no title)
        
      </div>
    </a>
  
  
    <a href="/2021/12/24/Day618-The%20Economist/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title"></div>
    </a>
  
</nav>

  
</article>

<!-- Table of Contents -->

  <aside id="sidebar">
    <div id="toc" class="toc-article" style="overflow-y: scroll; max-width: 28%;">
    <strong class="toc-title">Contents</strong>
    
      <ol class="nav"><li class="nav-item nav-level-1"><a class="nav-link" href="#What-to-expect-in-year-three-of-the-pandemic"><span class="nav-number">1.</span> <span class="nav-text">What to expect in year three of the pandemic</span></a><ol class="nav-child"><li class="nav-item nav-level-6"><a class="nav-link" href="#The-World-Ahead-2022"><span class="nav-number">1.0.0.0.0.1.</span> <span class="nav-text">The World Ahead 2022</span></a></li></ol></li><li class="nav-item nav-level-5"><a class="nav-link" href="#New-antibody-and-antiviral-treatments-and-better-vaccines-are-on-the-way"><span class="nav-number">1.0.0.0.1.</span> <span class="nav-text">New antibody and antiviral treatments, and better vaccines, are on the way</span></a></li></ol></li></ol></li></ol></li></ol></li></ol>
    
    </div>
  </aside>
</section>
        
      </div>
      <footer id="footer" class="site-footer">
  

  <div class="clearfix container">
      <div class="site-info">
	      &copy; 2023 Yujie&#39;s Blog All Rights Reserved.
          
            <span id="busuanzi_container_site_uv">
              本站访客数<span id="busuanzi_value_site_uv"></span>人次  
              本站总访问量<span id="busuanzi_value_site_pv"></span>次
            </span>
          
      </div>
      <div class="site-credit">
        Theme by <a href="https://github.com/iTimeTraveler/hexo-theme-hiero" target="_blank">hiero</a>
      </div>
  </div>
</footer>


<!-- min height -->

<script>
    var contentdiv = document.getElementById("content");

    contentdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";
</script>

<!-- Custome JS -->

<script src="/js/my.js"></script>

    </div>
    <!-- <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
    <a href="/categories" class="mobile-nav-link">Categories</a>
  
    <a href="/tags" class="mobile-nav-link">Tags</a>
  
    <a href="/about" class="mobile-nav-link">About</a>
  
</nav> -->
    

<!-- mathjax config similar to math.stackexchange -->

<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    tex2jax: {
      inlineMath: [ ['$','$'], ["\\(","\\)"] ],
      processEscapes: true
    }
  });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
      }
    });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax(), i;
        for(i=0; i < all.length; i += 1) {
            all[i].SourceElement().parentNode.className += ' has-jax';
        }
    });
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>



  
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.css">

  
<script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.js"></script>




<script src="/js/scripts.js"></script>


<script src="https://stackpath.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>


<script src="/js/main.js"></script>








  <div style="display: none;">
    <script src="https://s95.cnzz.com/z_stat.php?id=1260716016&web_id=1260716016" language="JavaScript"></script>
  </div>



	<script async src="https://dnqof95d40fo6.cloudfront.net/atw7f8.js">
	</script>






  </div>

  <a id="rocket" href="#top" class=""></a>
  <script type="text/javascript" src="/js/totop.js" async=""></script>
</body>
</html>
